Dose-dependent absorption of amoxycillin and bacampicillin.
about
Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data.Determination of dose-dependent absorption of amoxycillin from urinary excretion data in healthy subjects.Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers.The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsPathogen shifts and changing cure rates for otitis media and tonsillopharyngitis.Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis.Hollow-fiber pharmacodynamic studies and mathematical modeling to predict the efficacy of amoxicillin for anthrax postexposure prophylaxis in pregnant women and children.Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid.Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model.Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers.Use of an enzyme-linked immunosorbent assay to assess penetration of amoxicillin into lung secretions.Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.No effect of omeprazole-induced hypoacidity on the bioavailability of amoxycillin or bacampicillin.Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints.Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin and Synulox in healthy dogs.Thalidomide dose proportionality assessment following single doses to healthy subjects.A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.Pharmacokinetic comparison of two models of endocarditis prophylaxis with amoxycillin.Pharmacokinetics of a new oral formulation of amoxicillin.
P2860
Q33364320-42068E11-818F-408C-AC16-F52F19880DAAQ34346322-6053718B-5BEA-4AF1-AFA8-207325C1CDE8Q34447289-878AE135-400A-452F-A03A-43A77FE71604Q36468109-8CBBE71A-1BD1-4DC0-A673-C6C09C05E607Q36559049-DA07A7AE-129D-4121-A6DC-3A958CA52A83Q37013231-EADD4EB7-5C7D-4A48-B3B5-50D4E8A67741Q37335844-0C53F087-4F90-4A5A-9431-0890D818DE2AQ37535947-FB052445-7638-409C-9763-B2CAFCC711B2Q38667875-8BD28483-3FA2-4A82-96E4-4EDB613CAF0CQ39557754-5FB15281-91F4-4138-B07E-D508EB7DD41CQ39785421-5C0118B3-6CD6-4368-A66F-6C44B463FBCBQ39879711-0B2E6F8D-2F62-4FAB-88D9-8EA35FC67A12Q40285623-3B131371-6F64-4A9B-BDC7-1F4977B90FF7Q41856412-FA522191-6EB7-4A3C-930F-772B5465D0D0Q42101630-B9B642C7-7126-4F24-8F01-146B08B1609FQ42599582-8D4D4435-8B07-41E2-9E1F-C7871CBCC833Q43637283-FBFE8004-CBDC-4DDB-AAE4-0AF17FEE4157Q43782295-B6A14C9E-8A56-4725-8054-30D8EAF8E44CQ45232561-6EF787DF-CBC7-4EC4-9F78-AAEB80B86623Q53976559-B26595EC-FDCE-42B6-9D7F-093CB54585E9
P2860
Dose-dependent absorption of amoxycillin and bacampicillin.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Dose-dependent absorption of amoxycillin and bacampicillin.
@en
type
label
Dose-dependent absorption of amoxycillin and bacampicillin.
@en
prefLabel
Dose-dependent absorption of amoxycillin and bacampicillin.
@en
P2093
P356
P1476
Dose-dependent absorption of amoxycillin and bacampicillin.
@en
P2093
P2888
P304
P356
10.1038/CLPT.1985.166
P407
P577
1985-09-01T00:00:00Z
P6179
1009049093